-+ 0.00%
-+ 0.00%
-+ 0.00%

GENPREX SIGNS EXCLUSIVE TECHNOLOGY LICENSE AGREEMENT WITH NEW YORK UNIVERSITY LANGONE HEALTH FOR THE TREATMENT OF MESOTHELIOMA

Reuters·04/28/2025 11:30:02

Please log in to view news